Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Five years of clinical experience with metronomic chemotherapy: achievements and perspectives.

× No keyword cloud information.

11 in total

1. Metronomic chemotherapy in combination with antiangiogenic treatment induces mosaic vascular reduction and tumor growth inhibition in hepatocellular carcinoma xenografts.

Authors: Fan Zhou; Juan Hu; Jiang-Hua Shao; Shu-Bing Zou; Shun-Li Shen; Zhi-Qiang Luo
Journal: J Cancer Res Clin Oncol Date: 2012-06-27 Impact factor: 4.553

2. Capecitabine "metronomic" chemotherapy for palliative treatment of elderly patients with advanced gastric cancer after fluoropyrimidine-based chemotherapy.

Authors: ShengLi He; Jie Shen; Liang Hong; LuMing Niu; DaoYong Niu
Journal: Med Oncol Date: 2011-01-25 Impact factor: 3.064

3. Tumors that acquire resistance to low-dose metronomic cyclophosphamide retain sensitivity to maximum tolerated dose cyclophosphamide.

Authors: Urban Emmenegger; Giulio Francia; Annabelle Chow; Yuval Shaked; Andrew Kouri; Shan Man; Robert S Kerbel
Journal: Neoplasia Date: 2011-01 Impact factor: 5.715

Review 4. Combination of antiangiogenesis with chemotherapy for more effective cancer treatment.

Authors: Jie Ma; David J Waxman
Journal: Mol Cancer Ther Date: 2008-12 Impact factor: 6.261

5. Metronomic gemcitabine in combination with sunitinib inhibits multisite metastasis and increases survival in an orthotopic model of pancreatic cancer.

Authors: Hop S Tran Cao; Michael Bouvet; Sharmeela Kaushal; Alex Keleman; Eric Romney; Ginna Kim; John Fruehauf; David K Imagawa; Robert M Hoffman; Matthew H G Katz
Journal: Mol Cancer Ther Date: 2010-07-06 Impact factor: 6.261

Review 6. Metronomic Capecitabine Effectively Blocks Leptomeningeal Carcinomatosis From Breast Cancer: A Case Report and Literature Review.

Authors: Michela Maur; Claudia Omarini; Federico Piacentini; Annalisa Fontana; Elisa Pettorelli; Stefano Cascinu
Journal: Am J Case Rep Date: 2017-02-28

7. Bevacizumab in the treatment of HER2-negative breast cancer.

Authors: Vito Lorusso
Journal: Biologics Date: 2008-12

8. Potential relevance of bell-shaped and u-shaped dose-responses for the therapeutic targeting of angiogenesis in cancer.

Authors: Andrew R Reynolds
Journal: Dose Response Date: 2010-04-23 Impact factor: 2.658

9. Metronomic capecitabine in patients with hepatocellular carcinoma unresponsive to or ineligible for sorafenib treatment: report of two cases.

Authors: Sara Marinelli; Alessandro Granito; Fabio Piscaglia; Matteo Renzulli; Angela Stagni; Luigi Bolondi
Journal: Hepat Mon Date: 2013-09-09 Impact factor: 0.660

Review 10. Metronomic chemotherapy and anti-angiogenesis: can upgraded pre-clinical assays improve clinical trials aimed at controlling tumor growth?

Authors: Klas Norrby
Journal: APMIS Date: 2013-10-26 Impact factor: 3.205